Massachusetts Financial Services’s Veradermics Inc MANE Stock Holding History

Massachusetts Financial Services’s Portfolio MANE Stock Details MANE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.2M	Buy	+147,841	New	+$13.8M	0.01%	683

Other funds holding MANE

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

FMI

F/M Investments Washington, District of Columbia $1.97B AUM 30.33% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Massachusetts Financial Services's MANE Position: Q2 2026 in Review

Massachusetts Financial Services opened a new position in Veradermics Inc (MANE) in Q2 2026: 147,841 shares worth $18.2M. The stake represents 0.01% of the portfolio and ranks #683 among its holdings.

31 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

Massachusetts Financial Services held 147,841 shares of Veradermics Inc worth $18.2M as of Q2 2026.
Veradermics Inc was a new Massachusetts Financial Services position in Q2 2026.
Veradermics Inc made up 0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #683 holding.
31 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.